ACADIA Pharmaceuticals rocketed to 64% gains yesterday on good news regarding its Parkinson's disease treatment ... but let's not put the cart before the horse. More
-
-
Sponsored By:
-
Sponsored By:
Pharmaceuticals
Obama’s Budget: Industry Winners and Losers
After unveiling his 2014 budget yesterday, President Obama was attacked by both the right and the left. Here are the industries most affected by the proposal. More
Bulls vs. Bears: Can Biogen Keep Booming?
Biogen has been soaring on news of its recent drug approval, but the question remains when it can keep it up. Here are the bullish and bearish arguments. More
Judge OKs No-Prescription ‘Morning-After Pill’ for All Ages
A federal judge has ordered the Food and Drug Administration to abandon its decision to require a prescription for minors to purchase emergency contraception. More
Trade of the Day: Eli Lilly (LLY)
April has a history of being a strong month, though it's not a guarantee. Here's a pharmaceutical stock that should benefit no matter how the month turns out. More
India Drops Patent Bomb on Novartis
India's ruling on a Novartis patent draws a clear line of favor between generic drug companies and Big Pharma. More
Novartis Loses Important Patent Battle
A long-running battle by Novartis to gain a patent for an updated cancer drug in India has been struck down by the country's supreme court. More
